Member Info for TorquayFan

Chester and all - thanks for the posts. Scancell are indeed nursing a long list of opportunities. But after the announcement that the heroic RG had stepped in, I was expecting a 'permanent' appointment by now - there must be lots of work for the CBO to do !

Ruck - just catching up and well spotted. I see I omitted my usual indicator i.e. . . . . . .
I agree Inan's post was most helpful.

RW - 'but' - is this enough ?

Inan's 51706 today :-

"On the run down to news, it does not matter what Scancell has presented from the science point ... for the simple reason "In Human" results over ride all that's gone before. All you can do is look at that current data presented and take a position. I suspect once the market fully opens in September then an upward push on the SP will occur.

September is the last month before the last Qtr.....with news expected on all fronts ........... by then

if Moditope works a land grab of that arena ..... SIPTM

if Immunobody MK3 works better than MK2 ...... seriously exciting as that also gives gravitas to Avidmab

if SCIB1 works it gives Mk3 immunobody a massive boost to work with Checkpoints

and of course news on Glymab could come anytime

what is known ......... SCIB1 works without checkpoint ..........

no reason exists why it would not work with

and Modi1 seems to be getting past the "danger phase" of toxicity, no rns = good news

so it does not matter whats posted .........

all down to position before news

The current Market Cap barely covers one success in only one indication

but Scancell products are platforms ... from one grows many"

A great summary from Inan which brings emphasis to the question about having an 'I'CBO - is this enough?

I'm noting that Richard Goodfellow is still 'interim' Chief Business Officer. 'Interim' is normally temporary or provisional but Richard now appears in 'Scancell speak', to be permanent ! No disrespect to RG but ?

Prof Lindy listed amongst the Speakers in Basel 2022 . . . .

https://www.terrapinn.com/conference/festival-of-biologics/speakers.stm

Marcus also posted this https://www.nanopass.com/micronjet-microneedle-device/instructions-for-use/

Interesting but no mention of SCLP in their 'News' section . . . . .

Good sleuthing Cleaner - interesting dots - I wonder how/if they join up ?

... taking ...

Thanks Ivy - yes I saw the G link yesterday - (but I hoped the Indy one opened freely). I wonder if BioNTech are in the process of talking the Francis Crick ideas forward ?

Thanks for that info. Bermuda. So it seems this pic https://twitter.com/BioNTech_Group/status/1552332488890015744? is likely to be about this https://www.msn.com/en-gb/news/world/e2-80-98promising-e2-80-99-breakthrough-in-race-to-develop-e2-80-98holy-grail-e2-80-99-covid-vaccine-for-multiple-variants/ar-AA102cYP

That is, moreso than anything to do with Covidity. It seems to me that our CEO likes very much to go her own way. As we already have an 'established' liaison with BioNTech - I'm surprised that there has not evidently been interest from BioNTech in the Covidity project.
But I could be wrong - maybe they visited Prof. Lindy after the BJ meet ! (wink)

Merck spending big bucks - I wonder how this fits in . . . . .

https://www.bioworld.com/articles/521086-kelun-biotech-licenses-out-adc-for-solid-tumors-to-merck-in-936m-deal?v=preview

Good point Cleaner - was that pic taken in the UK ? Probably I guess ?

I see Mr and Mrs Sahin, although they're the central figures, are keeping a little distance from the great Man himself..

Let's hope the team visited Prof. Lindy at Scancell too ? ATB

Try this ? https://twitter.com/BioNTech_Group/status/1552332488890015744?s=20&t=qbefsXhpTRUvSvJ2GmnZyQ

Ruck - 'Just goes to show that people rec the poster and not what's written lol.'

It was ever thus Ruck. I'm sure you haven't just noticed it. Re. sarcastic recs - surely not - what would be the point ?

Thanks Cleaner. I also saw in the G words suggesting that existing vaccines were less effective against Omicron than previous infection ? When I looked to post it, I couldn't find it. I wonder if you saw that ?

IF the data for Covidity is good it should be a candidate for the task of 'booster'.

Chester you say, 'I'm not an expert on all things financial'. Neither am I.

It is important that misinfo on here is corrected. As it happens, on this occasion I think AB is correct in what he has been saying about the CLN's as explained by other posters too.

Anyway, cheer up.

Nice post C7 and I'm pleased to see you're battling on as ever. I had been wondering how you were doing . . . . TCOY

" . . . recent research shows that previous infection with an older variant (such as Alpha, Beta or Delta) offers some protection against reinfection with BA.4 or BA.5, and that a prior Omicron infection is substantially more effective" . . (in conferring protection) . .

"The immunity you’re getting from these Omicron infections actually protects you from other Omicron sub-lineages to some extent,” says Sigal. However, “COVID is everywhere,” Sato warns. “It can easily evolve into a new variant.”

https://www.nature.com/articles/d41586-022-01950-2?

It'd be interesting to see how protection via vax compares with protection from previous infections.

I also wondered how immunity from Tcells as distinct from immunity from antibodies might be affecting these early findings . . . . .

For us LTH, some data on Covidity is eagerly awaited to see if it is likely to help at all.

Hi Violin - coiled spring eh ? I'd never have guessed (wink).
Basically I'm the same as you but time expired !
I see SP dropped 50p back again. Bigger. News would be nice . . . . .

Violin - it's just a few buys. It would be nice if News arrives tomorrow but don't rely on it. Anyday could be no news, some news or big news - impossible to tell. ATB